Medicare AdvantagePrior AuthMedium impact
Lynkuet® (elinzanetant) (New)
Humana·OB-GYN, Family Medicine, Internal Medicine +2 more·Medicare Advantage
Effective date
Jan 28, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for Lynkuet (elinzanetant), a new medication for moderate to severe menopause-related hot flashes. Patients must have tried hormone therapy or antidepressants first, or be unable to use them.
Action Required
By January 28, 2026: Billing and clinical teams must obtain prior authorization before prescribing Lynkuet for Humana Medicare Advantage patients. Verify patients have tried hormone therapy or SSRI/SNRI medications first, or document contraindications. Use Humana's PAL website (www.humana.com/PAL) for authorization requests. Claims will be denied without proper prior authorization.